{
    "code": 0,
    "data": [
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31 2025.",
            "news_id": "5bcb52c9-5492-4fe6-aaf3-108da48b149f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc699e4f-05b6-40ff-90e4-86189ee75d00.pdf",
            "news_date": "2026-02-03 16:52:57",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter and nine months ended December 31 2025",
            "news_id": "6976c8c4-c508-468f-b6f0-8b9525cff60b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e6853af-1a57-4bb8-964f-8b9fb7bc8010.pdf",
            "news_date": "2026-01-30 20:38:31",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Strides Press release on Q3 FY 26 financials",
            "news_id": "a7950f78-15b6-44cf-86a1-0762c22f19ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ada5c53-065b-4cf6-a49a-8e35f2171226.pdf",
            "news_date": "2026-01-30 12:56:23",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": " Un-Audited Financial Results (Consolidated & Standalone) \r\nFor The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Unaudited financial results for quarter and nine months ended December 31 2025",
            "news_id": "af508842-2a54-442c-9509-99742aeda575",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b2f87ed-dcea-451f-ab08-edef5b9f5709.pdf",
            "news_date": "2026-01-30 12:49:42",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter and half year ended September 30 2025",
            "news_id": "07cfb255-5e11-4183-9ea0-09540fdbe1f7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebb37d52-a27e-4beb-8f15-1f1b2f5e966e.pdf",
            "news_date": "2025-10-31 20:56:17",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Consolidated & Standalone) For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Consolidated & Standalone) for the quarter and half year ended September 30 2025",
            "news_id": "69ad4d6a-bf21-4a29-a5c0-9447334a8fd3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab75eac0-a270-452f-8dbe-111914b96f17.pdf",
            "news_date": "2025-10-31 13:05:22",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter ended June 30 2025.",
            "news_id": "3d106277-bf46-4eb0-ba90-642871ba774e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f34981f1-c07a-4bcf-b5e6-231a4daae171.pdf",
            "news_date": "2025-07-29 20:57:25",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results (Consolidated & Standalone) For The Quarter Ended June 30 2025",
            "news_body": "Financial Results (Consolidated & Standalone) for the quarter ended June 30 2025",
            "news_id": "5110c0c2-dcee-42a8-967e-e64759751c7a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33ebd29e-37e3-4ccf-a60a-57710ecbdd0b.pdf",
            "news_date": "2025-07-29 12:33:42",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Audited Financial Results for the quarter and financial year ended March 31 2025",
            "news_id": "98b483eb-5a97-480e-a461-7d2bd3b3101f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b72086bc-8a4e-436c-b5e3-f4f980a236d5.pdf",
            "news_date": "2025-05-22 19:12:14",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Of The Company Held On May 22 2025",
            "news_body": "Outcome of Board Meeting of the Company held on May 22 2025",
            "news_id": "bfe200db-0c2e-4a67-af50-dd7f2b4fc68a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b30c80ec-3405-467c-903a-716f508a8306.pdf",
            "news_date": "2025-05-22 13:33:53",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2024.",
            "news_id": "aa9ebb03-2d66-4975-9c93-f6515c7bde63",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c7fb38e-4d7b-4cf0-ba27-66648bac5e65.pdf",
            "news_date": "2025-01-30 13:21:51",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the Un-Audited Financial Results for the quarter and half-year ended September 30, 2024",
            "news_id": "6900a9ef-ce7c-4101-83c6-2b0e526441a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=022c4317-c8c1-4f4a-a328-989f03fbc9fd.pdf",
            "news_date": "2024-10-24 19:18:58",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For Quarter And Half-Year Ended September 30, 2024",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) for quarter and half year ended September 30, 2024.",
            "news_id": "9dbcffbf-a621-40b1-88a5-ec2f0e5ffd8c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=342ea0a4-93f8-4caf-a592-b6e368b9f9de.pdf",
            "news_date": "2024-10-24 13:19:07",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For Quarter Ended June 30, 2024",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) for quarter ended June 30, 2024.",
            "news_id": "f51b55b4-160a-4187-bd9f-1c74a442a5ed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e79339fc-b780-4534-8aea-c180814ad730.pdf",
            "news_date": "2024-07-29 14:05:11",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - May 22, 2024",
            "news_body": "Outcome of Board Meeting - May 22, 2024",
            "news_id": "0203fc79-9407-4b06-b309-34c1b551c269",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=416d7b90-0799-4297-bf31-4e2d5c685010.pdf",
            "news_date": "2024-05-22 13:43:47",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We would like to inform you that Management of Strides will be meeting investors/ analysts during the week of February 5, 2024.The investor deck which will be considered during these meetings is enclosed for your reference.",
            "news_id": "0bc289e7-8f00-42c2-ba32-2c5925d8b773",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe3ada58-ceee-4d6f-a372-390e314b16a7.pdf",
            "news_date": "2024-02-02 21:16:49",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Outcome of Board Meeting - Un-audited Financial Results (Standalone & Consolidated) for quarter and nine months ended December 31, 2023",
            "news_id": "291db42e-25ef-434c-b511-559fb6734869",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6d1d1ed-c4de-4160-af27-6cecd0887f76.pdf",
            "news_date": "2024-01-30 13:16:55",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Earnings Call - Audio recording",
            "news_id": "97dcd60b-8509-499c-b202-4ce408665c6a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d201d823-a062-4706-a9fb-a53efd23721b.pdf",
            "news_date": "2023-10-30 17:40:14",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For Quarter And Half Year Ended September 30, 2023",
            "news_body": "Outcome of Board Meeting - Un-audited Financial Results (Standalone & Consolidated) for quarter and half year ended September 30, 2023.",
            "news_id": "189b9e2a-2591-4886-b216-856817de819a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b3fbfed-82b7-41b5-9b2b-5474ffac6665.pdf",
            "news_date": "2023-10-30 12:16:27",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors call held today, September 25, 2023",
            "news_id": "dadc5f55-5296-4d47-9462-23d0e7b884c1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c7fb29e-ebef-499a-a2f8-0ce949df018b.pdf",
            "news_date": "2023-09-25 19:00:09",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the un-audited Financial Results for the quarter ended June 30, 2023.",
            "news_id": "29d1006c-4578-4351-9f8e-e9040b291627",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28a81972-fd9b-4bf4-8938-b05452aceab2.pdf",
            "news_date": "2023-08-02 19:02:52",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For Quarter Ended June 30, 2023",
            "news_body": "Outcome of Board Meeting - Un-audited Financial Results (Standalone & Consolidated) for quarter ended June 30, 2023.",
            "news_id": "e5094d80-02b6-40ac-9366-c8c8113e289e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc66b2dc-6802-4d05-b0fb-96b8a37317d4.pdf",
            "news_date": "2023-08-02 11:51:45",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call transcript pertaining to Audited Financial Results for the quarter and year ended March 31, 2023.",
            "news_id": "51cc99f6-d051-4cb3-8c29-5967ff8236fb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6d49081-0415-4964-8893-1c31ae04c654.pdf",
            "news_date": "2023-06-01 10:48:49",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the Financial Results for the quarter and year ended March 31, 2023.",
            "news_id": "e5363367-adb5-4fd0-8d65-86860ea16487",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12279360-506b-40b4-8142-126ed21ccc85.pdf",
            "news_date": "2023-05-25 18:27:39",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Audited Financial Results (Standalone & Consolidated) For Quarter And Year Ended March 31, 2023",
            "news_body": "Outcome of Board Meeting - Audited Financial Results (Standalone & Consolidated) for quarter and year ended March 31, 2023",
            "news_id": "72c1849a-3f13-4080-9876-2f0a0f8affd2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=428e5cc4-15a5-43f5-9ea6-20284f19c156.pdf",
            "news_date": "2023-05-25 14:20:44",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the Financial Results for the quarter and nine months ended December 31, 2022",
            "news_id": "81b1b598-26bd-4308-9865-130bde0cb4b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25d627fd-b81f-4d10-83e4-1de5d200c5be.pdf",
            "news_date": "2023-01-25 10:13:25",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2022",
            "news_id": "ca8b402f-3387-4693-9f1f-ac87e6d76bac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3efab5e7-43c3-4425-9e95-f64cad905a0f.pdf",
            "news_date": "2023-01-24 14:41:10",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "With reference to above, please find enclosed the disclosure of Related Party Transactions, on consolidated basis, for the half year ended September 30, 2022.This is for your information and records.",
            "news_id": "1bd7ee5a-01f9-418a-a6f1-cde711bfb937",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae0a8a35-b0b9-4eb4-83f8-e150b49d3776.pdf",
            "news_date": "2022-11-28 20:51:17",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the Financial Results for the  quarter and half year ended September 30, 2022",
            "news_id": "b8bb4fdd-e5a4-4909-98bc-caea46756a3b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3daf6f1-fda9-4eff-a738-ed95643189d6.pdf",
            "news_date": "2022-11-16 16:47:37",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2022",
            "news_id": "91b288aa-1593-4bf6-bce9-31d2a95d02f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fcbc544-bc51-4447-81ac-0a195f0a4c40.pdf",
            "news_date": "2022-11-14 15:17:59",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2022",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2022",
            "news_id": "76ce84f5-e3b0-43f2-b036-332df6b9296e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8592a91-fc18-4b51-ab5f-fc1561c455cf.pdf",
            "news_date": "2022-07-29 13:11:31",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "With reference to above, please find enclosed the disclosure of Related Party Transactions, on consolidated basis, for the half year ended March 31, 2022 in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021. This is for your information and records.",
            "news_id": "be8b8fbf-3878-48c5-bd20-a92d795ce393",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86a69b94-4cb9-4825-8282-36d0015712b1.pdf",
            "news_date": "2022-06-08 19:07:43",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the  Financial Results for the  Quarter and Financial Year Ended March 31, 2022.",
            "news_id": "c387f3d7-d698-4cfd-b683-b293c92fc23d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=397504ad-5046-4e38-9300-e54d350223ef.pdf",
            "news_date": "2022-05-25 14:34:12",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended March 31, 2022",
            "news_body": "Outcome of Board Meeting - Audited Financial Results (Standalone & Consolidated) for the quarter and year ended March 31, 2022",
            "news_id": "e72d7773-f78f-494b-8dff-fbcc7a358ef2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f14edf4f-fdb8-4c9e-a26d-7fe192e8fad7.pdf",
            "news_date": "2022-05-24 21:31:53",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "We are pleased to enclose the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter and nine months ended December 31, 2021, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard.<BR> <BR> The board meeting commenced at 11:30 hrs and concluded at 13:10 hrs.<BR> <BR> This is for your information and record.",
            "news_id": "bd64542e-3b7d-45d3-aa82-fc52281fa5d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a5b176c-7ce3-410b-b854-4bb710e827a8.pdf",
            "news_date": "2022-02-10 13:24:52",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "We are pleased to enclose the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter and half year ended September 30, 2021, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard.<BR> <BR> The board meeting commenced at 11:00 hrs and concluded at 13:30 hrs.<BR>  <BR> This is for your information and record.",
            "news_id": "293f80ed-8756-4802-8b1a-bd430406da9c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=653f56b3-9041-4a19-90b3-9f55c51b4251.pdf",
            "news_date": "2021-11-10 13:45:44",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2021",
            "news_body": "We are pleased to enclose the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter ended June 30, 2021, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard.<BR> <BR> The board meeting commenced at 10:15 hrs and concluded at 12:20 hrs.<BR> <BR> This is for your information and record.",
            "news_id": "6c718b94-55ce-42d6-8ba7-fb49ede4b017",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ba27bd4-de70-40d2-9ba1-294b8677ffd2.pdf",
            "news_date": "2021-08-06 12:47:26",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "With reference to above, please find enclosed the disclosure of Related Party Transactions, on consolidated basis, for the year ended March 31, 2021 drawn in accordance with applicable accounting standards.<BR>  <BR> This is for your information and records.",
            "news_id": "ee368fac-59ac-4309-bc2a-ffdcceda0fdc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5dfa4437-e5a2-41c9-9b32-1f36f6b7181d.pdf",
            "news_date": "2021-06-25 11:34:07",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended March 31, 2021",
            "news_body": "The Board of Directors at their meeting held today i.e., on May 27, 2021, has inter-alia, approved the Audited Financial Statements (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2021.  <BR> <BR> In this regard, please find enclosed the following:<BR> <BR> 1. A copy of the Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended March 31, 2021 along with Auditors' Report for the said period;<BR> <BR> 2. Declaration on Unmodified Opinion in the Auditors' Report for Financial Year ended March 31, 2021; and<BR> <BR> 3. Press Release tilted 'Strides reports strong FY21 performance with 29% revenue and 67% EBITDA growth'.<BR> <BR> The Board Meeting commenced at 11:45 hrs and concluded at 13:15 hrs.<BR> <BR> This is for your information and record.",
            "news_id": "c1c57d3c-d44c-42e0-aef8-4e5cd622a757",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=705a7878-b9a6-421d-884a-47dfc3af9eb7.pdf",
            "news_date": "2021-05-27 13:33:32",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}